15-May-2024
TipRanks (Tue, 14-May 9:10 AM ET)
BioLife Solutions Reports First Quarter 2024 Financial Results
PRNewswire (Thu, 9-May 4:03 PM ET)
BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
PRNewswire (Tue, 30-Apr 4:13 PM ET)
BioLife Solutions Announces the Divestiture of its Stirling Freezer Business
PRNewswire (Thu, 18-Apr 8:05 AM ET)
BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences
PRNewswire (Mon, 4-Mar 8:03 AM ET)
BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results
PRNewswire (Thu, 29-Feb 4:03 PM ET)
PRNewswire (Tue, 20-Feb 8:03 AM ET)
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Biolife Solns trades on the NASDAQ stock market under the symbol BLFS.
As of May 15, 2024, BLFS stock price climbed to $22.99 with 448,104 million shares trading.
BLFS has a beta of 3.22, meaning it tends to be more sensitive to market movements. BLFS has a correlation of 0.31 to the broad based SPY ETF.
BLFS has a market cap of $1.06 billion. This is considered a Small Cap stock.
Last quarter Biolife Solns reported $32 million in Revenue and -$.20 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.08.
In the last 3 years, BLFS stock traded as high as $60.67 and as low as $8.92.
The top ETF exchange traded funds that BLFS belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.
BLFS stock has underperformed the market in the last year with a return of +18.1%, while SPY returned +29.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BLFS shares. However, BLFS has outperformed the market in the last 3 month and 2 week periods, returning +26.4% and +31.5%, while SPY returned +5.8% and +5.9%, respectively. This indicates BLFS has been having a stronger performance recently.
BLFS support price is $21.42 and resistance is $23.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BLFS stock will trade within this expected range on the day.